SG11201506494XA - Methods for purifying antibodies - Google Patents

Methods for purifying antibodies

Info

Publication number
SG11201506494XA
SG11201506494XA SG11201506494XA SG11201506494XA SG11201506494XA SG 11201506494X A SG11201506494X A SG 11201506494XA SG 11201506494X A SG11201506494X A SG 11201506494XA SG 11201506494X A SG11201506494X A SG 11201506494XA SG 11201506494X A SG11201506494X A SG 11201506494XA
Authority
SG
Singapore
Prior art keywords
methods
purifying antibodies
antibodies
purifying
Prior art date
Application number
SG11201506494XA
Inventor
Kent E Goklen
Eric J Suda
Antonio Raul Ubiera
Original Assignee
Glaxosmithkline Ip No 2 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50391244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201506494X(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Ip No 2 Ltd filed Critical Glaxosmithkline Ip No 2 Ltd
Publication of SG11201506494XA publication Critical patent/SG11201506494XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804Affinity chromatography
    • B01D15/3809Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
SG11201506494XA 2013-03-15 2014-03-13 Methods for purifying antibodies SG11201506494XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361787309P 2013-03-15 2013-03-15
PCT/IB2014/059755 WO2014141150A1 (en) 2013-03-15 2014-03-13 Methods for purifying antibodies

Publications (1)

Publication Number Publication Date
SG11201506494XA true SG11201506494XA (en) 2015-09-29

Family

ID=50391244

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201506494XA SG11201506494XA (en) 2013-03-15 2014-03-13 Methods for purifying antibodies

Country Status (15)

Country Link
US (2) US10676503B2 (en)
EP (3) EP3680000B1 (en)
JP (2) JP6599773B2 (en)
KR (1) KR102114021B1 (en)
CN (1) CN105188872B (en)
AU (1) AU2014229280B2 (en)
BR (1) BR112015022321A2 (en)
CA (1) CA2902287A1 (en)
DK (2) DK3680000T3 (en)
ES (1) ES2765206T3 (en)
IL (1) IL240753B (en)
RU (1) RU2651483C2 (en)
SG (1) SG11201506494XA (en)
TW (1) TWI625335B (en)
WO (1) WO2014141150A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2765206T3 (en) * 2013-03-15 2020-06-08 Glaxosmithkline Ip No 2 Ltd Antibody purification procedures
JP2016519145A (en) 2013-05-15 2016-06-30 メディミューン リミテッド Purification of recombinantly produced polypeptides
EP3137186B1 (en) 2014-04-30 2021-01-27 Novo Nordisk A/S Methods for the purification of proteins using caprylic acid
WO2016121701A1 (en) 2015-01-26 2016-08-04 株式会社カネカ AFFINITY SEPARATION MATRIX FOR PURIFYING PROTEIN CONTAINING IMMUNOGLOBULIN κ CHAIN VARIABLE REGION
WO2016121703A1 (en) 2015-01-26 2016-08-04 株式会社カネカ MUTANT IMMUNOGLOBULIN κ CHAIN VARIABLE REGION-BINDING PEPTIDE
WO2017195638A1 (en) 2016-05-09 2017-11-16 株式会社カネカ Method for refining antibody or antibody fragment containing κ-chain variable region
EP4389757A2 (en) * 2016-09-07 2024-06-26 GlaxoSmithKline Intellectual Property Development Limited Methods for purifying antibodies
CN106939045B (en) * 2017-05-01 2020-03-31 深圳市国创纳米抗体技术有限公司 Method for clarifying monoclonal antibody cell culture solution
CN108085358A (en) * 2018-02-08 2018-05-29 保定冀中药业有限公司 A kind of preparation method of canine parvovirus monoclonal antibody IgG2b-Fab segments
TW202003555A (en) * 2018-03-07 2020-01-16 英商葛蘭素史克智慧財產發展有限公司 Methods for purifying recombinant polypeptides
TW202000891A (en) 2018-03-07 2020-01-01 英商葛蘭素史克智慧財產發展有限公司 Methods for purifying antibodies
CN114133446A (en) * 2021-12-31 2022-03-04 方坦思(上海)生物医药有限公司 Method for purifying monoclonal antibody

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57106673A (en) 1980-12-24 1982-07-02 Chugai Pharmaceut Co Ltd Dibenzo(b,f)(1,4)oxazepin derivative
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
US6955917B2 (en) 1997-06-20 2005-10-18 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
ATE455468T1 (en) * 2001-06-01 2010-02-15 Upfront Chromatography As FRACTIONATION OF MIXTURES CONTAINING PROTEIN
EP2277914A3 (en) 2001-08-10 2012-08-08 Aberdeen University Antigen binding domains from fish
KR20050026396A (en) 2002-05-31 2005-03-15 인디언 카운실 오브 애그리컬쳐럴 리서치 Rapid detection of bt-cry toxins
ES2407380T5 (en) 2004-02-27 2017-07-07 Octapharma Ag Procedure to provide a purified antibody preparation, with no risk for viruses
EP1786827A4 (en) * 2004-05-14 2008-10-29 Kirin Holdings Kk Methods for immunoglobulin purification
WO2007109163A2 (en) * 2006-03-16 2007-09-27 Amgen Inc Wash buffer and method of using
US20080167450A1 (en) * 2007-01-05 2008-07-10 Hai Pan Methods of purifying proteins
DK2691411T3 (en) * 2011-03-29 2020-05-11 Glaxosmithkline Llc PROTEIN PURIFICATION BUFFER SYSTEM
ES2765206T3 (en) * 2013-03-15 2020-06-08 Glaxosmithkline Ip No 2 Ltd Antibody purification procedures
JP2016519145A (en) 2013-05-15 2016-06-30 メディミューン リミテッド Purification of recombinantly produced polypeptides

Also Published As

Publication number Publication date
TW201522365A (en) 2015-06-16
AU2014229280B2 (en) 2017-01-05
JP2020019795A (en) 2020-02-06
KR20150131235A (en) 2015-11-24
KR102114021B1 (en) 2020-05-22
EP2969098A1 (en) 2016-01-20
ES2765206T3 (en) 2020-06-08
AU2014229280A1 (en) 2015-10-01
EP4371996A2 (en) 2024-05-22
TWI625335B (en) 2018-06-01
US20200277330A1 (en) 2020-09-03
CA2902287A1 (en) 2014-09-18
WO2014141150A1 (en) 2014-09-18
BR112015022321A2 (en) 2017-07-18
CN105188872A (en) 2015-12-23
EP3680000B1 (en) 2024-03-13
US20160024146A1 (en) 2016-01-28
US10676503B2 (en) 2020-06-09
EP3680000A1 (en) 2020-07-15
CN105188872B (en) 2019-01-15
IL240753B (en) 2021-01-31
DK2969098T3 (en) 2020-01-27
JP2016519052A (en) 2016-06-30
RU2651483C2 (en) 2018-04-19
DK3680000T3 (en) 2024-04-02
IL240753A0 (en) 2015-10-29
RU2015136860A (en) 2017-04-28
JP7002511B2 (en) 2022-02-21
JP6599773B2 (en) 2019-10-30
EP2969098B1 (en) 2019-10-30

Similar Documents

Publication Publication Date Title
IL269528A (en) Anti-fcrh5 antibodies
HK1217344A1 (en) Purification process for monoclonal antibodies
PT3004163T (en) Method for purifying antibody
GB201322583D0 (en) Antibodies
IL240753B (en) Methods for purifying antibodies
HK1220142A1 (en) Antibodies
GB201308658D0 (en) Antibodies
EP2987801A4 (en) Method for purifying antibody protein
GB201315486D0 (en) Antibodies
IL245488A0 (en) Anti-ccl17 antibodies
GB201318283D0 (en) Antibodies